We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Northwest Biotherapeutics Inc (QB) | USOTC:NWBO | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00594 | 1.29% | 0.46594 | 0.4633 | 0.47 | 0.479 | 0.45505 | 0.465 | 616,167 | 21:30:42 |
| | | | | 2 | | | |
| | | | | 2 | | | |
| | | | | 5 | | | |
| | | | | 7 | | | |
| | | | | 9 | | | |
| | | | | 11 | | | |
| | | | | 14 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | A-1 | | |
Name of Beneficial Owner
|
| |
Number of
Shares Beneficially Owned |
| |
Percentage
(1)
|
| ||||||
Officers and Directors | | | | ||||||||||
Alton L. Boynton, Ph.D.
(2)
|
| | | | 2,493,490 | | | | | | * % | | |
Marnix L. Bosch, Ph.D., M.B.A.
(3)
|
| | | | 5,940,754 | | | | | | 1.4 % | | |
Linda F. Powers
(4)
|
| | | | 109,849,800 | | | | | | 21.3 % | | |
Leslie J. Goldman
(5)
|
| | | | 11,778,471 | | | | | | 2.8 % | | |
Dr. Navid Malik
(6)
|
| | | | 5,109,062 | | | | | | 1.2 % | | |
Jerry Jasinowski
(7)
|
| | | | 4,774,137 | | | | | | 1.1 % | | |
J. Cofer Black
(8)
|
| | | | 964,687 | | | | | | * % | | |
All executive officers and directors as a group (7 persons)
|
| | | | 140,910,401 | | | | | | 25.8 % | | |
5% Security Holders | | | | ||||||||||
Cognate BioServices, Inc.
(9)
4800 East Shelby Drive Suite 108, Memphis, TN |
| | | | 124,621,395 | | | | | | 23.7 % | | |
Woodford Investment Management LLP
(10)
9400 Garsington Road Oxford OX4 2NH, UK |
| | | | 24,815,028 | | | | | | 6.0 % | | |
| By Order of the Board of Directors, | |
|
/s/ Linda F. Powers
|
|
| Chairperson of the Board of Directors | |
1 Year Northwest Biotherapeutics (QB) Chart |
1 Month Northwest Biotherapeutics (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions